Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1245547.RA-Gnzp04ZUqrm9E_4frEoV2Aewq_dCrrJG7D9N4bb1nM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1245547.RA-Gnzp04ZUqrm9E_4frEoV2Aewq_dCrrJG7D9N4bb1nM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1245547.RA-Gnzp04ZUqrm9E_4frEoV2Aewq_dCrrJG7D9N4bb1nM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1245547.RA-Gnzp04ZUqrm9E_4frEoV2Aewq_dCrrJG7D9N4bb1nM130_provenance.
- NP1245547.RA-Gnzp04ZUqrm9E_4frEoV2Aewq_dCrrJG7D9N4bb1nM130_assertion description "[Our findings suggest that miR-136 may function as an anti-oncogene and deficiency of miR-136 expression in ovarian cancer can induce chemoresistance at least in part by downregulating apoptosis and promoting the repair of cisplatin-induced DNA damage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245547.RA-Gnzp04ZUqrm9E_4frEoV2Aewq_dCrrJG7D9N4bb1nM130_provenance.
- NP1245547.RA-Gnzp04ZUqrm9E_4frEoV2Aewq_dCrrJG7D9N4bb1nM130_assertion evidence source_evidence_literature NP1245547.RA-Gnzp04ZUqrm9E_4frEoV2Aewq_dCrrJG7D9N4bb1nM130_provenance.
- NP1245547.RA-Gnzp04ZUqrm9E_4frEoV2Aewq_dCrrJG7D9N4bb1nM130_assertion SIO_000772 25482209 NP1245547.RA-Gnzp04ZUqrm9E_4frEoV2Aewq_dCrrJG7D9N4bb1nM130_provenance.
- NP1245547.RA-Gnzp04ZUqrm9E_4frEoV2Aewq_dCrrJG7D9N4bb1nM130_assertion wasDerivedFrom befree-2016 NP1245547.RA-Gnzp04ZUqrm9E_4frEoV2Aewq_dCrrJG7D9N4bb1nM130_provenance.
- NP1245547.RA-Gnzp04ZUqrm9E_4frEoV2Aewq_dCrrJG7D9N4bb1nM130_assertion wasGeneratedBy ECO_0000203 NP1245547.RA-Gnzp04ZUqrm9E_4frEoV2Aewq_dCrrJG7D9N4bb1nM130_provenance.
- befree-2016 importedOn "2016-02-19" NP1245547.RA-Gnzp04ZUqrm9E_4frEoV2Aewq_dCrrJG7D9N4bb1nM130_provenance.